1
|
Torregrosa C, Pernot S, Vaflard P, Perret A, Tournigand C, Randrian V, Doat S, Neuzillet C, Moulin V, Stouvenot M, Roth G, Darbas T, Auberger B, Godet T, Jaffrelot M, Lambert A, Dubreuil O, Gluszak C, Bernard‐Tessier A, Turpin A, Palmieri L, Bouche O, Goujon G, Lecomte T, Sefrioui D, Locher C, Grados L, Gignoux P, Trager S, Nassif E, Saint A, Hammel P, Lecaille C, Bureau M, Perrier M, Botsen D, Bourgeois V, Taieb J, Auclin E. FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX‐bevacizumab failure for COlorectal cancer (BEFLICO): an AGEO multicenter study. Int J Cancer 2022; 151:1978-1988. [DOI: 10.1002/ijc.34166] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2021] [Revised: 04/20/2022] [Accepted: 04/26/2022] [Indexed: 11/05/2022]
Affiliation(s)
- Cécile Torregrosa
- Gastrointestinal Oncology Department, Hôpital Européen Georges Pompidou, AP‐HP, Université de Paris Paris France
| | - Simon Pernot
- Medical oncology Bergonié Institute Bordeaux France
| | | | - Audrey Perret
- Department of Cancer Medicine Gustave Roussy Cancer Institute Villejuif France
| | - Christophe Tournigand
- Medical Oncology, Henri Mondor Hospital, Assistance Publique des Hôpitaux de Paris Paris Est Creteil University, INSERM, IMRB F‐94010 Creteil France
| | - Violaine Randrian
- Hepatology and Gastro‐enterology Department University Hospital Center of Poitiers Poitiers France
| | - Solene Doat
- Digestive Oncology Department Pitié‐Salpêtrière University Hospital, Assistance Publique des Hôpitaux de Paris Paris France
| | - Cindy Neuzillet
- Medical Oncology Department Curie Institute, Saint‐Cloud, Versailles Saint‐Quentin ‐ Paris Saclay University France
| | - Valérie Moulin
- Oncology Department Hospital of La Rochelle La Rochelle France
| | - Morgane Stouvenot
- Department of Oncology University Hospital Center of Besançon Besançon France
| | - Gael Roth
- Hepato‐gastroenterology and Digestive oncology Unit University Hospital Center of Grenoble Grenoble France
| | - Tiffany Darbas
- Oncology Department University Hospital Center of Limoges Limoges France
| | - Benjamin Auberger
- Oncology Department University Hospital Center of Brest Brest France
| | - Tiphaine Godet
- Gastroenterology and digestive oncology department University Hospital Center of Angers Angers France
| | - Marion Jaffrelot
- Digestive Oncology Department University Hospital Center of Toulouse Toulouse France
| | - Aurélien Lambert
- Medical Oncology Department, Institut de Cancérologie de Lorraine Nancy France
| | - Olivier Dubreuil
- Medical Oncology Department Diaconesses‐Croix St Simon Hospital Paris
| | - Cassandre Gluszak
- Medical Oncology department Institut de Cancérologie de l'Ouest Angers France
| | - Alice Bernard‐Tessier
- Gastroenterology and Digestive Oncology Department, Saint‐Antoine Hospital, APHP Paris France
| | - Anthony Turpin
- University of Lille, CNRS UMR9020, Inserm UMR‐S 1277 ‐ Canther ‐ Cancer Heterogeneity, Plasticity and Resistance to Therapies, Lille University Hospital, Department of Medical Oncology Lille France
| | - Lola‐Jade Palmieri
- Gastroenterology and Digestive Oncology Department Cochin Hospital, APHP. Paris France
| | - Olivier Bouche
- Oncology Department University Hospital Center of Reims Reims France
| | - Gael Goujon
- Gastroenterology and Digestive Oncology Department Bichat Hospital Paris France
| | - Thierry Lecomte
- Department of Hepato‐Gastroenterology and Digestive Oncology, Tours University Hospital and INSERM U1069 Nutrition, Croissance et Cancer University of Tours Tours France
| | - David Sefrioui
- Normandie Univ, UNIROUEN, Inserm U1245, IRON group Rouen University Hospital, Normandy Centre for Genomic and Personalized Medicine and Department of Hepatogastroenterology, F 76000 Rouen France
| | - Christophe Locher
- Gastroenterology and Digestive Oncology Department Meaux Hospital Meaux France
| | - Lucien Grados
- Gastroenterology and Digestive Oncology Department University Hospital Center of Amiens Amiens France
| | - Pauline Gignoux
- Oncology Department University Hospital Center of Martinique Fort de France France
| | | | - Elise Nassif
- Oncology Department Leon Berard Institute Lyon France
| | - Angélique Saint
- Medical oncology department Antoine Lacassagne Center Nice France
| | - Pascal Hammel
- Digestive and medical oncology department University Paris‐Saclay, Hospital Paul Brousse (AP‐HP), Villejuif France
| | - Cédric Lecaille
- Gastroenterology Department Polyclinique Bordeaux Nord Aquitaine Bordeaux France
| | - Mathilde Bureau
- Digestive oncology department University Hospital Center of Nantes Nantes France
| | - Marine Perrier
- Gastroenterology and Digestive Oncology Department Boulogne‐Sur‐Mer Hospital, Boulogne‐Sur‐Mer France
| | - Damien Botsen
- Oncology Department University Hospital Center of Reims Reims France
| | - Vincent Bourgeois
- Gastroenterology and Digestive Oncology Department Boulogne‐Sur‐Mer Hospital, Boulogne‐Sur‐Mer France
| | - Julien Taieb
- Gastrointestinal Oncology Department, Hôpital Européen Georges Pompidou, AP‐HP, Université de Paris Paris France
| | - Edouard Auclin
- Gastrointestinal Oncology Department, Hôpital Européen Georges Pompidou, AP‐HP, Université de Paris Paris France
| |
Collapse
|
2
|
Issoufaly I, Andraud M, Lonca L, Gignoux P, Nourrit M, Bougas S, Escarmant P, Ducreux M, Encaoua J, Delaye M, Khettab M. L’internat d’oncologie en outre-mer français. Bull Cancer 2022; 109:232-240. [DOI: 10.1016/j.bulcan.2022.01.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2021] [Revised: 12/24/2021] [Accepted: 01/03/2022] [Indexed: 10/19/2022]
|
3
|
Abstract
The proposed study consists in moving several bones such as pelvis, femur and tibia in conditions as similar as possible to those obtained in a walking subject, to evidence the functioning of this hip and knee joints. The analysis is performed during the stance phase when the joints are loaded. This study is the first phase of a research consisting in: (i) the visualization of the motion of joints in both normal and pathologic subjects; and (ii) the calculation in real time of articular loading caused by muscular forces when sustaining both the external and inertial loads. This research will provide the kinematic and dynamic boundary conditions applied to both a knee and a hip prosthesis of the patient in movement.
Collapse
Affiliation(s)
- P Gignoux
- Fundamental Biomechanics Laboratory University of Lyon, Villeurbanne, France
| | | | | | | |
Collapse
|